PlainRecalls
FDA Drug Moderate Class II Terminated

VIVITROL (naltrexone for extended-release injectable suspension) a) 380 mg vial NDC 65757-303-02, b) 380 mg vial in kit NDC 65757-300-01, Rx Only Manufactured and marketed by Alkermes, Inc., Waltham, MA 02451,

Reported: July 31, 2013 Initiated: November 6, 2012 #D-819-2013

Product Description

VIVITROL (naltrexone for extended-release injectable suspension) a) 380 mg vial NDC 65757-303-02, b) 380 mg vial in kit NDC 65757-300-01, Rx Only Manufactured and marketed by Alkermes, Inc., Waltham, MA 02451,

Reason for Recall

Lack of Assurance of Sterility: Product did not meet the criteria for container closure integrity testing during routine 24 month stability testing.

Details

Recalling Firm
Alkermes, Inc.
Units Affected
3,325 vials
Distribution
Nationwide
Location
Waltham, MA

Frequently Asked Questions

What product was recalled?
VIVITROL (naltrexone for extended-release injectable suspension) a) 380 mg vial NDC 65757-303-02, b) 380 mg vial in kit NDC 65757-300-01, Rx Only Manufactured and marketed by Alkermes, Inc., Waltham, MA 02451,. Recalled by Alkermes, Inc.. Units affected: 3,325 vials.
Why was this product recalled?
Lack of Assurance of Sterility: Product did not meet the criteria for container closure integrity testing during routine 24 month stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 31, 2013. Severity: Moderate. Recall number: D-819-2013.